Tr. Fennell et Cd. Brown, A physiologically based pharmacokinetic model for ethylene oxide in mouse,rat, and human, TOX APPL PH, 173(3), 2001, pp. 161-175
Ethylene oxide (EO) is widely used as a gaseous sterilant and industrial in
termediate and is a direct-acting mutagen and carcinogen. The objective of
these studies was to develop physiologically based pharmacokinetic (PB-PK)
models for EO to describe the exposure-tissue dose relationship in rodents
and humans. We previously reported results describing in vitro and in vivo
kinetics of EO metabolism in male and female F344 rats and B6C3F1 mice, The
se studies were extended by determining the kinetics of EO metabolism in hu
man liver cytosol and microsomes. The results indicate enzymatically cataly
zed GSH conjugation via cytosolic glutathione S-transferase (cGST) and hydr
olysis via microsomal epoxide hydrolase (mEH) occur in both rodents and hum
ans. The in vitro kinetic constants were scaled to account for cytosolic (c
GST) and microsomal (mEH) protein content and incorporated into PB-PK descr
iptions for mouse, rat, and human. Flow-limited models adequately predicted
blood and tissue EO levels, disposition, and elimination kinetics determin
ed experimentally in rats and mice, with the exception of testis concentrat
ions, which were overestimated. Incorporation of a diffusion-limited descri
ption for testis improved the ability of the model to describe testis conce
ntrations. The model accounted for nonlinear increases in blood and tissue
concentrations that occur in mice on exposure to EO concentrations greater
than 200 ppm. Species differences are predicted in the metabolism and expos
ure-dose relationship, with a nonlinear relationship observed in the mouse
as a result of GSH depletion, These models represent an essential step in d
eveloping a mechanistically based EO exposure dose-response description for
estimating human risk from exposure to EO. (C) 2001 Academic Press.